2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 29587666 | Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer's perspective. | 2018 Mar 27 | 3 |
| 2 | 28751244 | Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line Treatment of Advanced EGFR-Mutated Advanced Non-Small Cell Lung Cancers. | 2017 Oct | 1 |